Literature DB >> 25602106

New therapeutic target for non-small-cell lung cancer.

Sharan Prakash Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25602106     DOI： 10.1016/s1470-2045(14)70493-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Forkhead box N1 inhibits the progression of non-small cell lung cancer and serves as a tumor suppressor.

Authors:  Xiaojian Ji; Yan Ji; Wenqing Wang; Xinmei Xu
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

2.  Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.

Authors:  Lei Li; Ting-Ting Zeng; Bao-Zhu Zhang; Yan Li; Ying-Hui Zhu; Xin-Yuan Guan
Journal:  Cancer Biol Ther       Date:  2017-10-20       Impact factor: 4.742

3.  MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.

Authors:  Dandan Li; Changjun He; Junfeng Wang; Yanbo Wang; Jianlong Bu; Xianglong Kong; Dawei Sun
Journal:  Oncol Res       Date:  2017-06-13       Impact factor: 5.574

4.  MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.

Authors:  Jiefang Li; Qinrong Wang; Ruiling Wen; Jieman Liang; Xiaoling Zhong; Wei Yang; Dongxiang Su; Jun Tang
Journal:  J Cell Mol Med       Date:  2015-08-18       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.